Fredun Pharmaceuticals Ltd
About
[
edit
]
Fredun Pharmaceuticals is engaged in Business of Pharmaceutical Formulations.
[
add key points
]
- Market Cap ₹ 233 Cr.
- Current Price ₹ 584
- High / Low ₹ 597 / 103
- Stock P/E 73.7
- Book Value ₹ 105
- Dividend Yield 0.00 %
- ROCE 10.4 %
- ROE 4.73 %
- Face Value ₹ 10.0
Pros
- Company's median sales growth is 33.96% of last 10 years
Cons
- Stock is trading at 5.56 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of 9.49% for last 3 years.
- Company's cost of borrowing seems high
- Promoter holding has decreased over last 3 years: -7.82%
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
21.03 | 16.52 | 22.10 | 26.56 | 32.23 | 28.33 | 31.90 | 27.86 | 25.30 | 13.74 | 33.60 | 45.57 | |
18.81 | 16.33 | 19.30 | 23.29 | 27.26 | 26.34 | 29.64 | 25.39 | 23.31 | 12.47 | 30.20 | 42.52 | |
Operating Profit | 2.22 | 0.19 | 2.80 | 3.27 | 4.97 | 1.99 | 2.26 | 2.47 | 1.99 | 1.27 | 3.40 | 3.05 |
OPM % | 10.56% | 1.15% | 12.67% | 12.31% | 15.42% | 7.02% | 7.08% | 8.87% | 7.87% | 9.24% | 10.12% | 6.69% |
Other Income | 0.00 | 0.00 | 0.00 | -0.64 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.16 | 0.00 |
Interest | 0.31 | 0.34 | 0.36 | 0.59 | 1.80 | 1.29 | 0.92 | 0.98 | 1.14 | 0.77 | 0.92 | 1.19 |
Depreciation | 0.43 | 0.48 | 0.17 | 0.33 | 0.35 | 0.46 | 0.47 | 0.48 | 0.47 | 0.46 | 0.49 | 0.53 |
Profit before tax | 1.48 | -0.63 | 2.27 | 1.71 | 2.82 | 0.24 | 0.87 | 1.01 | 0.38 | 0.04 | 0.83 | 1.33 |
Tax % | 50.00% | 0.00% | 0.00% | 0.00% | 60.28% | 0.00% | 0.00% | 0.00% | 155.26% | 0.00% | 0.00% | 0.00% |
Net Profit | 0.74 | -0.63 | 2.26 | 1.71 | 1.12 | 0.23 | 0.88 | 1.02 | -0.21 | 0.04 | 0.83 | 1.34 |
EPS in Rs | 2.16 | -1.84 | 5.66 | 4.29 | 2.81 | 0.58 | 2.21 | 2.56 | -0.53 | 0.10 | 2.08 | 3.36 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4 | 5 | 8 | 12 | 15 | 21 | 25 | 42 | 57 | 60 | 97 | 113 | 118 | |
3 | 4 | 7 | 11 | 14 | 20 | 24 | 38 | 53 | 54 | 87 | 104 | 108 | |
Operating Profit | 0 | 0 | 1 | 0 | 1 | 1 | 2 | 4 | 3 | 6 | 10 | 8 | 10 |
OPM % | 13% | 9% | 10% | 3% | 9% | 7% | 7% | 9% | 6% | 10% | 11% | 7% | 8% |
Other Income | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 | -1 |
Interest | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 4 | 4 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
Profit before tax | 0 | 0 | 0 | -0 | 0 | 0 | 1 | 2 | 2 | 3 | 6 | 2 | 3 |
Tax % | 45% | 6% | 67% | 0% | 80% | 47% | 52% | 42% | 36% | 34% | 28% | 24% | |
Net Profit | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 1 | 1 | 2 | 4 | 2 | 2 |
EPS in Rs | 0.26 | 0.60 | 0.09 | -1.02 | 0.04 | 1.02 | 1.11 | 4.55 | 6.08 | 5.11 | 11.18 | 4.76 | 5.01 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 13% | 10% | 12% | 6% | 14% |
Compounded Sales Growth | |
---|---|
10 Years: | 37% |
5 Years: | 35% |
3 Years: | 26% |
TTM: | -2% |
Compounded Profit Growth | |
---|---|
10 Years: | 30% |
5 Years: | 48% |
3 Years: | 11% |
TTM: | -3% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 60% |
1 Year: | 245% |
Return on Equity | |
---|---|
10 Years: | 10% |
5 Years: | 11% |
3 Years: | 9% |
Last Year: | 5% |
Balance Sheet
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 5 | 3 | 4 | 4 | 4 | |
Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 19 | 35 | 37 | 38 |
Borrowings | 3 | 4 | 4 | 5 | 5 | 7 | 9 | 16 | 18 | 10 | 19 | 35 | 18 |
2 | 2 | 3 | 6 | 7 | 8 | 11 | 24 | 33 | 47 | 47 | 57 | 83 | |
Total Liabilities | 8 | 9 | 10 | 13 | 15 | 18 | 23 | 43 | 56 | 79 | 105 | 133 | 143 |
5 | 5 | 5 | 6 | 6 | 7 | 8 | 15 | 16 | 16 | 31 | 31 | 31 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 4 | 11 | 0 | 0 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
3 | 4 | 5 | 7 | 9 | 11 | 14 | 29 | 36 | 52 | 74 | 102 | 112 | |
Total Assets | 8 | 9 | 10 | 13 | 15 | 18 | 23 | 43 | 56 | 79 | 105 | 133 | 143 |
Cash Flows
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0 | -1 | 0 | 0 | 1 | -1 | 2 | 3 | 4 | 17 | 1 | -11 | |
-1 | -0 | -1 | 0 | -1 | -2 | -3 | -6 | -7 | -8 | -5 | -1 | |
1 | 1 | 1 | 0 | -0 | 2 | 1 | 3 | 3 | -8 | 4 | 14 | |
Net Cash Flow | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 1 | -1 | 1 | 0 | 2 |
Ratios
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROCE % | 9% | 9% | 10% | 9% | 17% | 14% | 14% | 25% | 18% | 16% | 21% | 10% |
Debtor Days | 64 | 91 | 56 | 52 | 47 | 59 | 75 | 98 | 131 | 94 | 67 | 106 |
Inventory Turnover | 2.28 | 1.90 | 3.24 | 3.46 | 3.17 | 3.76 | 4.10 | 3.85 | 4.51 | 3.24 | 2.13 | 1.83 |
Documents
Add documentRecent announcements
- Announcement Under Regulation 30 (LODR)- Company''s Way Forward 23 Feb
- Announcement under Regulation 30 (LODR)-Newspaper Publication 16 Feb
- Outcome Of Board Meeting Held On 12Th February,2021 12 Feb
- Announcement under Regulation 30 (LODR)-Newspaper Publication 29 Jan
- Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December,2020 28 Jan
View all